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Oxidative stress and apoptosis are implicated in tendon degeneration. Peroxiredoxin 5 (PRDX5) is a novel thioredoxin peroxidase
recently identified in mammals, participating directly in eliminating hydrogen peroxide (H2O2) and neutralizing other reactive oxygen species
(ROS). We have previously reported that PRDX5 is upregulated in degenerative human tendon. However, the effects of this upregulation on
human tendon cell function remain unknown, in particular, with regards to oxidative stress conditions. Here we report that exposure of human
tendon cells to 50 AM H2O2 for 24 h (in vitro oxidative stress) caused a significant increase in the percentage of apoptotic cells (P< 0.05) as
assessed by flow cytometric analysis of Annexin V binding, accompanied by increased PRXD5 mRNA and protein expression.
Overexpression of PRDX5 in human tendon cells via transfection inhibited H2O2-induced tendon cell apoptosis by 46% (P< 0.05), and
prevented the decrease in tendon cell collagen synthesis which occurs under H2O2 challenge, although the decrease in collagen synthesis was
small. Results from our study indicate that the antioxidant enzyme PRDX5 plays a protective role in human tendon cells against oxidative
stress by reducing apoptosis and maintaining collagen synthesis.
D 2004 Elsevier B.V. All rights reserved.Keywords: Hydrogen peroxide (H2O2); Tendon cell; Transfection; Antioxidant; Collagen synthesis
1. Introduction Apoptosis, or programmed cell death, is an importantTendon degeneration is a common and often debilitating
condition. The key histological characteristics of tendon
degeneration are alterations of both collagen fibers and the
tendon cellular components [1]. It is well known that
fibroblasts represent the predominant cell type within ten-
don. The loss of fibroblast function affects the collagen
synthesis and contributes to tendon degeneration. However,
the precise nature of tendon degeneration, including the
cellular and molecular bases of tendon degeneration,
remains largely unknown. Our previous studies suggested
that excessive apoptosis might contribute to tendon degen-
eration [2].0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: Murrell.g@ori.org.au (G.A.C. Murrell).physiological process involved in cell deletion during or-
ganogenesis and in the control of cell proliferation and
differentiation in adult tissues. It is also involved in the
pathologies of many age-related degenerative diseases.
Recent studies have demonstrated that apoptosis can be
induced by oxidative stress, a condition in which reactive
oxygen species (ROS) such as hydroxyl radicals (SOH),
nitric oxide (SNO), superoxide (O2
S) and hydrogen peroxide
(H2O2) are overproduced [3]. Oxidative modifications of
biological molecules such as proteins, lipids, and nucleic
acids are potentially harmful to living organisms and may
also contribute to tendon degeneration [4–6].
To protect themselves from oxidative attack, cells have
developed a wide range of antioxidant systems to inactivate
excessive ROS. During the past decade, peroxiredoxins
(PRDXs), a new family of antioxidant enzyme, have
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PRDXs have been characterized in mammals [7–9], all
of which participate directly in eliminating H2O2 and
neutralizing other oxidizing molecules [10]. They are
involved not only in oxidative stress protection mecha-
nisms but also in cell differentiation [11], proliferation [12],
immune response [13], and apoptosis [14,15]. A study of
the crystal structure of human peroxiredoxin 5 (PRDX5,
also known as PrxV/AOEB166/PMP20/ARC1 [8,16–18])
suggested that PRDX5 may have a broader activity against
ROS compared with other isoforms of PRDX and other
antioxidant enzymes [19]. We have previously reported that
PRDX5 is upregulated in degenerative human tendon [5].
However, effects of this upregulation on tendon cell
function and survival remain unknown.
Investigation of the protective role of PRDX5 against
tendon cell apoptosis and the decrease in extracellular
matrix synthesis during oxidative stress may help us to
develop better strategies for the prevention and treatment of
tendon degeneration. In the current study, we transfected
human tendon cells with PRDX5 cDNA (a cytosolic/perox-
isomal form), exposed them to hydrogen peroxide (H2O2)
and evaluated the effects of overexpression of PRDX5 on
human tendon cell apoptosis and tendon cell function under
oxidative stress.2. Materials and methods
2.1. Human tendon cell culture
Human tissue collection was approved by the South
Eastern Sydney Area Health Service Ethics Committee,
Australia. Human rotator cuff tendon samples were collect-
ed aseptically from patients undergoing rotator cuff repair
surgery. Tendon samples were digested with collagenase
(Sigma-Aldrich, St. Louis, MO) at 37 jC overnight. Tendon
fibroblasts were cultured in Dulbecco’s modified Eagle
medium (DMEM, Invitrogen, Melbourne, Australia) with
10% (v/v) fetal calf serum (FCS). Cells from second and
third passages were used for all experiments. H2O2 was used
to induce oxidative stress.
2.2. Plasmid construction and transfection
Human PRDX5 cDNA [8] was PCR-amplified using the
forward primer 5V-AGAGCCGAATTC GCCATGGCCC-
CAATCAAG-3V (EcoRI site underlined) and the reverse
primer 5V-GTGGCCGCGGCCGC GGTATGGGACTA-
GCTGGC-3V(NotI site underlined). The PCR product was
digested with EcoRI and NotI, and ligated into pCMS-
EGFP mammalian expression vector (BD PharMingen, San
Diego, CA). The insert coding for the cytosolic/peroxi-
somal form of PRDX5 (short form of the protein without
the mitochondrial targeting sequence) was sequenced on
ABI 377 automatic DNA sequencer (Perkin-Elmer, Well-esley, MA). The pCMS-EGFP without insertion served as
empty vector.
Tendon cell transfection was carried out using Lipofect-
amine PLUS reagent (Invitrogen) according to the manu-
facturer’s instructions. Empty vectors (pCMS-EGFP) were
included in every transfection experiment as the transfection
control.
2.3. Assessment on transfection efficiency and cytotoxicity
Transfection efficiency and cytotoxicity were detected by
enhanced green fluorescence protein (EGFP) expression
[20,21] and propidium iodide (PI) staining [22] using a
FACSCalibur cytometer (Becton Dickinson, San Jose, CA,
USA). Transfection efficiency was expressed as the percent-
age of EGFP-positive cells from the total cell population.
Cytotoxicity caused by transfection was measured by the
percentage of PI-positive cells.
Microscopic evaluation of EGFP-expressing cells was
also performed with a fluorescence microscope (Leica,
Postfach, Germany) equipped with standard FITC filters
set (FT 510; BP 450/90; LP 520).
2.4. RNA extraction and Northern blotting
Total RNA was extracted from cultured human tendon
fibroblasts using Trizol reagent (Invitrogen, Carlsbad, CA)
following the manufacturer’s instruction.
Northern blotting was performed as previously de-
scribed [23]. Denatured RNA samples were fractionated
by electrophoresis in a denatured 1% (w/v) agarose gel,
transferred onto a GeneScreen Plus nylon membrane
(NEN Life Science Products, Boston, MA), cross-linked
by ultraviolet cross-linker (UltraLum, Carson, CA), and
hybridized with [a-32P]dCTP labeled human PRDX5
cDNA probe. The blots were stripped and rehybridized
with [a-32P]dCTP labeled human h-actin cDNA probe
(Ambion, Inc., Austin, TX) for internal control. Density
ratios of the PRDX5 band to h-actin band were analyzed
by Bio-Rad Quantity One image quantification system
(Bio-Rad, Hercules, CA). The PRDX5 mRNA level after
H2O2 treatment was expressed as relative density (relative
density = ratio of sample/ratio of control 100) with con-
trols being cells without treatment.
2.5. Western blotting
Expression of PRDX5 protein was detected by immuno-
blotting using a polyclonal rabbit anti-human PRDX5
antibody as described previously [5,23]. At the time of
harvesting, cells were washed twice with PBS, and resus-
pended in Tris–HCl buffer (pH 7.4) containing a protease
inhibitor cocktail (2 Ag/ml leupeptin, 5 Ag/ml pepstatin A, 2
mg/ml of EDTA-Na2, 500 Ag/ml AEBSF and 1 Ag/ml E-
64). The cell suspension was sonicated (Vibra cell, Sonic
and Materials, Inc., Danbury, CT) on ice and centrifuged at
Fig. 1. Apoptotic and necrotic/late stage apoptotic cells in EGFP-positive
cell population detected by Annexin V-APC and PI staining. (A)
Transfected tendon cells were selected by gating on the EGFP-positive
cell population, with the position of the gate determined by the
untransfected cells (shaded region). The EGFP-positive cells were then
subjected to further analysis for Annexin V-APC (apoptotic) and PI
(necrotic/late stage apoptotic) subpopulations. (B) Dot plot diagram
representing typical apoptotic and necrotic cell population after gating on
EGFP-positive cells. The lower left gate shows the viable (intact) cells,
which are negative for PI and Annexin V-APC binding (APC/PI). The
area of RN contains the non-viable, necrotic/late stage apoptotic cells,
positive for Annexin V-APC binding and for PI uptake (APC+/PI+). The
area of RA represents the apoptotic cells, positive for Annexin V-APC and
negative for PI (APC+/PI).
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new tube, and protein concentrations were measured by
MicroBCA protein assay (Pierce, Rockford, IL) following
the manufacturer’s instruction.
Ten micrograms of protein were denatured by boiling for
5 min in 2% SDS sample buffer, fractionated by electro-
phoresis on 12.5% (w/v) SDS-polyacrylamide gel, and
electrophoretically transferred to a PVDF membrane (NEN
Life Science Products). The blots were blocked with 5% (w/
v) non-fat dry milk TTBS solution containing 25 mM Tris,
pH 7.5, 150 mM NaCl, 0.05% (w/v) Tween-20, incubated
for 1 h with anti-PRDX5 antibody at 1:2000 dilutions,
followed by horseradish peroxidase-conjugated anti-rabbit
secondary antibodies (Chemicon, Melbourne, Australia).
Immunoreactive bands were detected by ECL reagents.
The membranes were stripped with Restore Western blot
stripping buffer (Pierce) and reprobed using a rabbit anti-
human h-actin antibody as a housekeeping control. The
density ratios of the PRDX5 band to actin band were
analyzed using a Bio-Rad Quantity One image quantifica-
tion system (Bio-Rad). The PRDX5 protein level after H2O2
treatment was expressed as relative density (relative densi-
ty = ratio of sample/ratio of control 100) with controls
being cells without treatment.
2.6. Apoptosis assay by flow cytometry
Detection of apoptotic cells was based on the principle of
Annexin V binding to translocated plasma membrane phos-
phatidylserine (PS) as previously described [6,24]. PI was
used to test loss of cell membrane integrity, which is
indicative of necrotic and late apoptotic cells. Briefly, cells
were washed, trypsinized, pelleted, resuspended in staining
buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 5
mM CaCl2) containing 1 Ag/ml PI and 5 Al of Annexin V
(BD PharMingen), and incubated for 15 min. The cell
mixture was then subjected to analysis by a flow cytometer
(FACSCalibur, Becton Dickinson). A minimum of 3 104
events was collected from each sample. Analysis of the
multivariate data was performed with CELLQuestk soft-
ware (Becton Dickinson). Annexin V/PI, Annexin V+/
PI or Annexin V+/PI+ represented viable (intact) cells,
apoptotic cells, or necrotic cells, respectively. To detect the
apoptotic cells after transfection, the transfected cells were
selected by gating on the EGFP-positive cell population
(Fig. 1A) and further analyzed for different subpopulations
(Fig. 1B).
2.7. Collagen synthesis
Collagen synthesis of cultured human tendon cells was
assessed by measuring the collagenase-sensitive fraction of
proteins with incorporated [2–3-3H] proline, as described
by Diegelmann et al. [25] and Schaffer et al. [26] with
modification. Briefly, fibroblasts were seeded into six-well
plates and allowed to grow to confluence. Ascorbic acid at50 Ag/ml and 10 ACi L-[2–3-3H] proline (1 mCi/ml,
Amersham Pharmacia Biotech UK Limited, Buckingham-
shire, England) were added to each well 18 h before
harvesting. At the end of the incubation period, medium
was collected from each well. Cells were scraped in PBS
and sonicated. A 50 Al aliquot was saved after sonication for
DNA quantification. The sonicated cell suspension was
combined with the collected medium. Proteins in the mix-
ture were precipitated with TCA and centrifugation. The
final pellet was dissolved in sodium hydroxide (NaOH) and
neutralized by HCl and HEPES. One hundred microlitres of
a neutralized protein mixture were counted in scintillation
fluid to determine the total amount of [2–3-3H] proline
incorporated into newly synthesized proteins. To determine
the amount of [2–3-3H] proline incorporated into newly
synthesized collagen, 500 Al of neutralized protein mixture
Fig. 2. Effects of H2O2 on human tendon cell death. Human tendon cells
were treated with 50 AM H2O2 for 24 h. Cell death was measured by
Annexin V-FITC and PI staining using flow cytometry. Data plotted are
meanF S.E. of three separate experiments. *P< 0.05 when compared with
untreated control cells using unpaired student’s tests.
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Corp., Freehold, NJ) digestion overnight at 37 jC. The
reaction was terminated by the addition of TCA and tannic
acid. After centrifugation, a 1.0 ml aliquot of supernatant
was counted by a liquid scintillation counter (LS6500,
Beckman Instruments Inc., Fullerton, CA), representing
the newly synthesized collagen component. Parallel samples
were processed without the addition of collagenase as a
blank for the correction of nonspecific release of labeled
proline. Counts from this blank were subtracted from those
obtained from the collagenase digestion to yield collage-
nase-specific incorporation.
DNA contents of cells from each well were measured by
a fluorescence spectrophotometer (F-4000, Hitachi Ltd.,
Tokyo, Japan) using the Hoechst dye technique as described
by Labarca and Paigen [27]. Results of collagen synthesis
were normalized by DNA contents and expressed as cpm/Ag
DNA.
2.8. Statistical analysis
All values in the text and figures are expressed as the
meanF S.E. of n observations. Statistical analyses among
multiple experimental groups were performed using analysis
of variance (ANOVA) and unpaired two-tailed Student’s t-
tests. The confidence limit was predetermined at an alpha
level of 0.05.3. Results
3.1. H2O2 induced apoptosis of human tendon cells
In vitro oxidative stress was created by exogenous
hydrogen peroxide (H2O2). We have previously demonstrat-
ed that H2O2 induced human tendon cell apoptosis in a
dose- and time-dependent manner [6]. To induce the max-
imal percentage of apoptotic cells while keeping necrotic
cells minimal, 50 AM H2O2 was used in the current study.
Tendon cell apoptosis and necrosis were analyzed by flow
cytometry. Exposure of human tendon cells to 50 AM H2O2
for 24 h caused a significant increase in percentage of
apoptotic cells (P < 0.05) as assessed by Annexin V-FITC
and PI staining (Fig. 2).
3.2. H2O2 upregulated PRDX5 expression
The ability of H2O2 to modulate PRDX5 expression in
human tendon cells was evaluated. Expression of PRDX5
protein in human tendon cells was detected by Western
blotting (Fig. 3A), and expression levels were analyzed by
a densitometry program as shown in Fig. 3B. Exposure of
tendon cells to 50 AM H2O2 resulted in an increased
PRDX5 protein expression which started at 4 h, peaked
at 24 h, and returned to baseline at 48 h post-H2O2
challenge. This profile suggested an upregulation ofPRDX5 protein under oxidative stress. Parallel experiments
on cells without H2O2 treatment did not show PRDX5
protein upregulation.
To determine whether the changes in PRDX5 levels were
related to transcriptional or post-transcriptional events, we
carried out Northern blotting analysis on PRDX5 mRNA
expression. The effects of H2O2 on PRDX5 mRNA expres-
sion levels are illustrated in Fig. 3C. Similar to PRDX5
protein expression, there was a detectable basal PRDX5
mRNA expression in cultured human tendon cells, indicat-
ing that PRDX5 is constitutively expressed in human tendon
cells. Exposure of tendon cells to H2O2 resulted in a time-
dependent increase in PRDX5 mRNA (Fig. 3D). However,
PRDX5 mRNA expression remained high at 48 h after
H2O2 challenge, when the protein level already declined,
indicating a discrepancy between PRDX5 mRNA and
protein expression at a later stage of oxidative stress.
3.3. Overexpression of PRDX5 protein in human tendon
cells
The upregulation of PRDX5 in tendon cells may indicate
a protective role of PRDX5 in H2O2-induced oxidative
stress. To confirm this aspect, human PRDX5 gene was
constructed with an EGFP reporter gene and transfected into
cultured human tendon cells.
Transfection efficiency was monitored by EGFP expres-
sion using flow cytometry, which showed that 82F 1%
(n = 3) of cells expressed EGFP. Maximal EGFP expression
was detected 2 days after transfection and remained high
until 5 days after transfection. Cell death detected by PI
staining was consistently under 11% during the entire
procedure. Fluorescence microscopic examination of trans-
fected cells was also performed to detect the expression of
EGFP. EGFP was uniformly distributed throughout the
Fig. 3. Effect of H2O2 (50 AM) on human tendon cells PRDX5 mRNA and
protein expression at indicated times. (A) PRDX5 protein expression after
H2O2 treatment at indicated times was detected by Western blotting (upper
panel). Anti-h-actin antibody was used to ensure equal protein loading
(lower panel). (B) Densitometry analyses of the expression of PRDX5
protein level as a function of time normalized by h-actin. (C) mRNA levels
of PRDX5 after H2O2 challenge at indicated times determined by Northern
blotting using the PRDX5 probe. h-Actin probe was used to ensure equal
RNA loading. (D) Densitometry analyses of the PRDX5 mRNA levels
normalized by h-actin. The densitometry analyses of PRDX5 mRNA and
protein levels after H2O2 treatment were expressed as relative density
(relative density = ratio of sample/ratio of control 100) (controls are cells
without H2O2 treatment). Results are representative of three separate
experiments.
Fig. 4. Expression of EGFP and PRDX5 in transfected human tendon cells.
(A) Distribution of EGFP in tendon cells transfected with pCMS-EGFP
vector. Human tendon cells were transfected by Lipofectamine PLUS
reagent. Forty-eight hours after transfection, cells were analyzed for EGFP
expression by a fluorescence microscope. (B) Western blot analysis of
PRDX5 expression in untransfected cells, empty vector-transfected cells
and PRDX5 vector-transfected cells (48 h after transfection). (C)
Densitometry analyses of the expression of PRDX5 protein levels
normalized by h-actin. Human tendon cells were cultured and transfected
as described in Materials and methods. Results are representative of three
separate experiments. (For color see online version).
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was observed in untransfected cells.
Equal amounts of cellular protein from untransfected,
empty vector transfected and PRDX5 vector transfected
tendon cells were analyzed by Western blotting for
PRDX5 protein levels (Fig. 4B). As shown in Fig. 4C,
48 h after transfection, cells transfected with PRDX5
presented an increased expression of PRDX5 protein
compared to that transfected with empty vector anduntransfected cells, suggesting a successful PRDX5 trans-
fection and expression.
3.4. Overexpression of PRDX 5 protected tendon cells
against H2O2-induced apoptosis
In the current study, we evaluated the effects of PRDX5
overexpression on tendon cell apoptosis induced by H2O2
challenge.
Assessment of apoptosis by flow cytometry indicated that
cells transfected with PRDX5 were relatively more resistant
to H2O2 challenge with fewer cells undergoing apoptosis as
compared to cells transfected with empty vector (PRDX5
vector vs. empty vector, 8.6F 1.0% vs. 15.8F 2.5%,
Fig. 6. Effects of PRDX5 overexpression on collagen synthesis of human
tendon cells under H2O2 challenge. Untransfected or transfected (with
empty vector or PRDXX5 vector) human tendon cells were treated with
H2O2 (50 AM) for 24 h. Collagenase-sensitive [3H]-proline incorporation
was determined as described in Materials and methods. Data for
collagenase-sensitive [3H]-proline incorporation are calculated as cpm/Ag
DNA. Data plotted are meanF S.E. of six separate experiments. *P < 0.01
when compared with control cells (without H2O2 challenge) using unpaired
Student’s tests.
J. Yuan et al. / Biochimica et Biophysica Acta 1693 (2004) 37–4542P < 0.05) (Fig. 5). Without H2O2 challenge, there was no
statistical difference in the percentage of apoptotic cells
between PRDX5 and empty vector transfected cells
(8.4F 1.0% vs. 7.7F 1.2%, P= 0.69). Twenty-four hours
after H2O2 (50 AM) challenge, the empty vector-transfected
cells had a significant increase in percentage of apoptotic
cells (with H2O2 vs. without H2O2, 15.8F 2.5% vs.
8.4F 1.0%, P < 0.05) (Fig. 5). This was similar to the result
in untransfected cells [6]. However, when PRDX5-trans-
fected cells were exposed to H2O2 challenge under the same
conditions, there was no increase of apoptosis (with H2O2 vs.
without H2O2, 8.6F 1.0% vs. 7.7F 1.2%, P= 0.54) (Fig. 5),
suggesting that overexpression of PRDX5 prevented H2O2-
induced apoptosis.
3.5. Overexpression of PRDX 5 prevented the decrease in
collagen synthesis induced by H2O2
One of the most important functions of tendon cells is
collagen synthesis. Under oxidative stress, the collagen
synthesis of tendon cells was significantly decreased,
assessed by [3H]-proline incorporation (P < 0.01, Fig. 6).
To further investigate the effects of overexpression of
PRDX5 on tendon cellular function under H2O2 challenge,
we compared [3H]-proline incorporation in empty vector-
and PRDX5 vector-transfected cells with or without H2O2
challenge.
As shown in Fig. 6, empty vector-transfected cells
exhibited a significant decrease in collagen synthesis when
challenged by H2O2 (without H2O2 vs. with H2O2, 762F 10
vs. 652F 11 cpm/Ag DNA, P < 0.01), which was similar toFig. 5. Effects of overexpression of PRDX5 on H2O2-induced human
tendon cell apoptosis. Human tendon cells were transfected with empty or
PRDX5 vector. Forty-eight hours after transfection, the cells were treated
with H2O2 (50 AM) for 24 h. The percentages of apoptotic cells were
measured by Annexin V-APC and PI staining in EGFP-positive cell
population using flow cytometry. Data plotted are the meanF S.E. of three
separate experiments. *P < 0.05 when compared with empty vector-
transfected cells without H2O2 treatment, using unpaired Student’s tests.
**P < 0.05 when compared with H2O2-treated empty vector-transfected
cells, using unpaired Student’s tests.what was found in untransfected cells. This decrease was
not significant in cells transfected with PRDX5 (without
H2O2 vs. with H2O2, 755F 19 vs. 738F 18 cpm/Ag DNA,
P= 0.79), indicating a protective role of PRDX5 overex-
pression on tendon cell function under conditions of oxida-
tive stress.4. Discussion
We have previously shown that PRDX5 is upregulated [5]
in tendon degeneration. Differential expression of PRDX5 in
normal and degenerative tendons suggest the involvement of
oxidative stress and antioxidant defence mechanisms in
tendon degeneration processes. In the current study, using
an in vitro oxidative stress model (i.e., exposing human
tendon cells to H2O2), we have demonstrated an upregulation
of both PRDX5 mRNA and protein under oxidative stress
and confirmed our previous hypothesis [5] that tendon cells
have the potential to increase their antioxidant status under
oxidative stress. During the time we observed PRDX5
expression, we noted a discrepancy between PRDX5 mRNA
and protein levels in H2O2-challenged tendon cells. Indeed,
PRDX5 protein levels had returned to baseline by 48 h after
H2O2 stimulation while the mRNA level remained high (Fig.
5). Similar phenomena were also noted in TNFa-stimulated
human chondrocytes [23]. This difference may be due to a
translational block in the synthesis of PRDX5 protein, which
may happen around 48 h after initial PRDX5 upregulation as
a feedback protection mechanism, as physiological levels of
ROS are essential for many biochemical processes including
signal transduction [28], cell differentiation and immunity
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mammalian cells and is believed to be responsible for the
discrepancy between mRNA and protein levels [30,31].
More experiments are necessary to define the translational
regulation of PRDX5 protein in human tendon cells.
Our findings that human tendon cells constitutively
express PRDX5, and the expression was upregulated by
the addition of H2O2, indicate that PRDX5 may play an
important role in protecting human tendon cells against
oxidative stress. Interestingly, after H2O2 challenge, the
tendon cells still underwent apoptosis despite increased
PRDX5 expression. It can therefore be hypothesized that
the upregulation of endogenous PRDX5 was insufficient to
prevent tendon cells from apoptosis under H2O2 challenge.
To evaluate the protective role of the cytosolic/peroxisomal
form of PRDX5 against oxidative stress, human tendon
fibroblasts were transfected with PRDX5 cDNA coding for
the short form of the protein without its mitochondrial
targeting sequence [8,16,18], exposed to H2O2, and exam-
ined for their rates of apoptosis and collagen synthesis.
Results from our study showed that overexpression of
PRDX5 had no effect on tendon cell apoptosis under normal
culture conditions. However, it prevented the H2O2-induced
tendon cell apoptosis.
Hydrogen peroxide (H2O2) is known to modulate a
variety of cellular functions [32]. It has been shown that a
low level of H2O2 (1 AM) stimulates tendon cell prolifera-
tion [33]. However, at higher concentrations, H2O2 leads to
tendon cell apoptosis in a dose- and time-dependent manner
as revealed in one of our recent studies [6]. Furthermore, we
have demonstrated that H2O2-induced tendon cell apoptosis
involves the release of mitochondrial cytochrome c and
activation of caspase-3. At present, the mechanisms by
which PRDX5 protects tendon cells against H2O2-induced
apoptosis are unclear. Seo et al. [16] have shown that
transient expression of the wild-type PRDX5 protein in
NIH3T3 cells inhibited H2O2 accumulation and activation
of c-Jun NH2-terminal kinase induced by TNF. Studies on
PRDXs in MCF-7 cells and thyroid cells suggest that the
protection provided by transfection of PRDXs against
H2O2-induced apoptosis most likely involves direct scav-
enging of intracellular H2O2 [34,35]. Overexpression of
PRDX 5 might directly eliminate H2O2 and block the
mitochondrial initial apoptotic pathway by preventing re-
lease of cytochrome c.
The well-known H2O2-removing enzymes are catalase
and glutathione peroxidase (GPX). PRDXs have only been
recognized in recent years for their roles in the detoxifica-
tion of H2O2. Although PRDXs have moderate peroxidatic
catalytic efficiencies (f 105 M 1 S 1) compared with
those of catalases (f 106 M 1 S 1) and GPX (f 108
M 1 S 1) [36], their high abundance in a wide range of
cells argue that they are indeed important players in H2O2
elimination in cells [36]. In fact, they are among the 10 most
abundant proteins in Escherichia coli [37], the second or
third most abundant protein in erythrocytes [38], andcompose 0.1–0.8% of the soluble protein in other mamma-
lian cells [39]. Compared with other members of PRDXs
family, PRDX5 is unique as it presents the widest subcel-
lular localization. A recent study by Banmeyer et al. [40]
has shown that overexpression of PRDX5 in cytosol caused
an increase in catalase and GPX activities, suggesting that
PRDX5 may protect catalase and GPX against oxidative
inactivation, enhancing the overall cellular antioxidant ca-
pacity. Whether this is the case in tendon cell requires
further investigation.
The causes of tendon degeneration are considered to be
decreased collagen synthesis by tendon cells and degrada-
tion of synthesed collagen in tendon matrix [41,42]. In the
current study, we have demonstrated that addition of H2O2
reduced collagen synthesis in tendon cells. These results are
consistent with the finding that oxidative stress by H2O2
decreased collagen synthesis in cardiac fibroblasts [43]. We
have also shown that overexpression of PRDX5 via gene
transfer prevented the decrease in tendon cell collagen
synthesis under oxidative stress. The protective effect of
PRDX5 on tendon cell collagen synthesis suggests that
PRDX5 may have pharmaceutical value in the prevention
and treatment of tendon degeneration.
In conclusion, our data have demonstrated that the
antioxidant enzyme PRDX5 is constitutively expressed in
human tendon fibroblasts. This expression is upregulated
under oxidative stress. H2O2 induces tendon cell apoptosis
and decreases collagen synthesis. These catabolic events are
prevented by overexpression of PRDX5 via gene transfer.
Results from our study indicate that the antioxidant enzyme
PRDX5 plays a protective role against oxidative stress by
maintaining cell metabolism and possibly the integrity of
tendon matrix. Oxidative stress has been shown to be
implicated in aging and specific degenerative conditions
[23,44–46]. The regulation of PRDX5 expression by gene
transfer might emerge as a novel approach for the preven-
tion and treatment of tendon degeneration. Further efforts
are necessary to fully elucidate the importance of PRDX5 in
the therapy of human degenerative tendon disorders.Acknowledgements
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